熊去氧胆酸临床应用进展

被引：40

作者：

刘娓娓

沈锡中

机构：

[1] 复旦大学附属中山医院消化科

来源：

世界临床药物 | 2003年 / 04期

关键词：

熊去氧胆酸; 肝疾病; 药物疗法;

D O I：

暂无

中图分类号：

R96 [药理学];

学科分类号：

100602 ; 100706 ;

摘要：

熊去氧胆酸作为一种溶解胆固醇性胆结石的常用药已越来越多地应用于各种肝疾病的治疗。本文就其作用机制及目前的临床应用作一综述。

引用

页码：213 / 216

页数：4

共 12 条

[1]

Motion – Patients with Primary Sclerosing Cholangitis Should Undergo Early Liver Transplantation: Arguments against the Motion[J] . Jeffrey S Crippin.Canadian Journal of Gastroenterology . 2002 (10)

[2] Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis [J].

Verma, A ;

Maxwell, JD ;

Ang, L ;

Davis, T ;

Hodges, S ;

Northfield, TC ;

Zaidi, M ;

Pazianas, M .

OSTEOPOROSIS INTERNATIONAL, 2002, 13 (08) :677-682

[3]

Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment[J] . Journal of Hepatology . 2002 (2)

[4]

Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: Effects on primary bile acids in babies and mothers[J] . Giuseppe Mazzella,Rizzo Nicola,Azzaroli Francesco,Simoni Patrizia,Bovicelli Luciano,Miracolo Anna,Simonazzi Giuliana,Colecchia Antonio,Nigro Giovanni,Mwangemi Constance,Festi Davide,Roda Enrico.Hepatology . 2001 (3)

[5]

Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C–dependent mechanisms in cholestatic rat liver[J] . Ulrich Beuers,Manfred Bilzer,Anila Chittattu,Gerd A. Kullak-Ublick,Dietrich Keppler,Gustav Paumgartner,Frank Dombrowski.Hepatology . 2001 (5)

[6] Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease [J].

Nousia-Arvanitakis, S ;

Fotoulaki, M ;

Economou, H ;

Xefteri, M ;

Galli-Tsinopoulou, A .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 32 (04) :324-328

[7] The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis [J].

Corpechot, C ;

Carrat, F ;

Bonnand, AM ;

Poupon, RE ;

Poupon, R .

HEPATOLOGY, 2000, 32 (06) :1196-1199

[8] Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon [J].

Poupon, RE ;

Bonnand, AM ;

Queneau, PE ;

Trépo, C ;

Zarski, JP ;

Vetter, D ;

Raabe, JJ ;

Thieffin, G ;

Larrey, D ;

Grangé, JD ;

Capron, JP ;

Serfaty, L ;

Chrétien, Y ;

Girardin, MFS ;

Mathiex-Fortunet, H ;

Zafrani, ES ;

Guéchot, J ;

Beuers, U ;

Paumgartner, G ;

Poupon, R .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (06) :642-649

[9] Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis [J].

Sasatomi, K ;

Noguchi, K ;

Sakisaka, S ;

Sata, M ;

Tanikawa, K .

JOURNAL OF HEPATOLOGY, 1998, 29 (03) :409-416

[10]

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: A pilot study[J] . J Laurin,KD Lindor,JS Crippin,A Gossard,GJ Gores,J Ludwig,J Rakela,DB McGill.Hepatology . 1996 (6)

← 1 2 →